Project Details
Description
PhosphoSer134 GR, TGF-beta and 14-3-3-zeta cooperate to promote progression of Triple Negative Breast Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/19 → 3/31/22 |
Funding
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.